EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers
Lijun Jiang(Hebei Medical University), Ka‐Leung Wong(Hong Kong Polytechnic University), Ga‐Lai Law(Hong Kong Polytechnic University), Chen Xie(Hong Kong Baptist University), Kwok Wai Lo(Chinese University of Hong Kong), Hong Lok Lung(Hong Kong Baptist University), Nai Ki Mak(Hong Kong Baptist University)
Cited by 78
Related Papers
Epstein–Barr virus infection and nasopharyngeal carcinoma
|Philosophical Transactions of the Royal Society B Biological Sciences|2017|583
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
|Journal of Clinical Oncology|2018|473
Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations
|Nature Communications|2017|336
The design of responsive luminescent lanthanide probes and sensors
|Chemical Society Reviews|2021|326
V2O5-modified Mn-Ce/AC catalyst with high SO2 tolerance for low-temperature NH3-SCR of NO
|Chemical Engineering Journal|2019|300